Drug Enforcement D-0348-2023

Failed Impurities/Degradation Specifications

Status

Terminated

Classification

Class II

Report Date

March 1, 2023

Termination Date

June 14, 2024

Product Information

Product description
Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01
Product quantity
12,216 bottles (100 count each)
Reason for recall
Failed Impurities/Degradation Specifications
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.

Location & Firm

Recalling firm
RISING PHARMACEUTICALS
Address
2 Tower Center Blvd, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0348-2023
Event ID
91713
Recall initiation date
February 15, 2023
Center classification date
February 23, 2023
Code info
Batch #: NB101596, Exp. 04/30/2023
More code info